- Home
- OBT vs AVIR Comparison
OBT vs AVIR Comparison
Compare OBT & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OBT | AVIR |
|---|---|---|
| Founded | 1892 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 457.5M | 429.1M |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | OBT | AVIR |
|---|---|---|
| Price | $37.48 | $5.29 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $36.00 | $10.00 |
| AVG Volume (30 Days) | 36.4K | ★ 216.2K |
| Earning Date | 04-28-2026 | 05-11-2026 |
| Dividend Yield | ★ 2.12% | N/A |
| EPS Growth | ★ 34.82 | 3.00 |
| EPS | ★ 1.87 | N/A |
| Revenue | N/A | ★ $351,367,000.00 |
| Revenue This Year | $14.27 | N/A |
| Revenue Next Year | $7.99 | N/A |
| P/E Ratio | $20.41 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $23.25 | $2.78 |
| 52 Week High | $40.10 | $6.45 |
Technical Indicators
Market Signals| Indicator | OBT | AVIR |
|---|---|---|
| Relative Strength Index (RSI) | 45.74 | 48.40 |
| Support Level | $35.50 | $5.13 |
| Resistance Level | $38.61 | $5.79 |
| Average True Range (ATR) | 1.25 | 0.20 |
| MACD | -0.03 | -0.06 |
| Stochastic Oscillator | 71.76 | 25.56 |
Price Performance
Historical ComparisonAbout OBT Orange County Bancorp Inc.
Orange County Bancorp Inc is a community bank holding company providing commercial and consumer banking services to individuals, small businesses, and local governments. It operates through two segments: Banking and Wealth Management. The Banking segment, the primary revenue driver, offers loans such as commercial real estate, construction, commercial & industrial, multifamily, and residential mortgages, along with services like cash management, escrow, deposits, ATMs, and digital banking. The Wealth Management segment provides investment management, trust services (trustee, administrator, custodian), and financial planning and advisory services to individuals and institutions.
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.